Researching: Novo Nordisk
Pulling real-time news, deal activity, and upcoming catalysts
Analyzing sources for "Novo Nordisk"...
RxInsider Coverage (7)
Money
Lilly’s Mounjaro Pricing Strategy: Gross-to-Net Math Behind Market Dominance
Mar 6
The Week
Weekly Pharma Roundup: Merck's $11B Bet, FDA Pushback, and Earnings Surprises
Feb 21
Pipeline
Late-Stage Obesity Drugs Beyond GLP-1s: Orforglipron, Survodutide, and the Oral Alternatives That Could Reshape Pricing
Feb 18
Pipeline
Obesity Pipeline Beyond GLP‑1s: Orforglipron, Survodutide, and the Oral Disruptors
Jan 27
Policy
IRA Price Negotiation Year One: Who Blinked, Who Balked, and What's Next for Big Ticket Drugs
Jan 22
Data
340B Contract Pharmacy Claims Data: The $53 Billion Question
Apr 10
The Week
The Week in Pharma: Novo Nordisk Supply Deal, FTC PBM Report, and a Biosimilar Price War
Mar 14
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.